NICOLS JOHN J 4

4 · CODEXIS, INC. · Filed Apr 19, 2023

Form 4

Period: 2023-04-17

Director

Transactions

Sale
Common Stock
[F1][F2]
2023-04-17$4.24/sh−35,714$151,377→ 783,965 total
Exercise/Conversion
Common Stock
[F1]
2023-04-18$1.97/sh+35,714$70,357→ 819,679 total
Sale
Common Stock
[F1][F3]
2023-04-18$4.14/sh−35,714$147,874→ 783,965 total
Exercise/Conversion
Stock Option (Right to Buy)
[F1]
2023-04-17−35,714→ 178,570 total
Exercise: $1.97From: 2018-02-24Exp: 2024-02-24→ Common Stock (35,714 underlying)
Exercise/Conversion
Stock Option (Right to Buy)
[F1]
2023-04-18−35,714→ 142,856 total
Exercise: $1.97From: 2018-02-24Exp: 2024-02-24→ Common Stock (35,714 underlying)
Exercise/Conversion
Common Stock
[F1]
2023-04-17$1.97/sh+35,714$70,357→ 819,679 total

Footnotes (3)

[F1]Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on August 31, 2022.
[F2]This transaction was executed in multiple trades in prices ranging from $4.08 to $4.36, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
[F3]This transaction was executed in multiple trades in prices ranging from $4.055 to $4.36, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.

Signature

/s/ Sriram Ryali, as Attorney-in-Fact for John J. Nicols|2023-04-19

Documents

1 file